Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Poxviral promoters for improving the immunogenicity of MVA delivered vaccines

28 Aug 2018

Abstract excerpt

Modified vaccinia virus Ankara (MVA) is a replication-deficient poxvirus, attenuated in chick embryo fibroblast primary cells. It has been utilised as a viral vector to develop many vaccines against cancer and infectious diseases such as malaria, HIV/AIDS, influenza, and tuberculosis, MERS-CoV, and Ebola virus infection. There is accumulating data from many preclinical and clinical studies that highlights the...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Herpesvirus Infections and Treatments
Share to Poxvirus research and outbreaks
Share to vaccines and immunoinformatics approaches

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 30148692
DOI: 10.1080/21645515.2018.1513439

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Poxviral promoters for improving the immunogenicity of MVA delivered vaccinesPMID 30148692Read ↗

A Novel Naturally Occurring Tandem Promoter in Modified Vaccinia Virus Ankara Drives Very Early Gene Expression and Potent Immune ResponsesSemantic proximity Read ↗

Expression and Cellular Immunogenicity of a Transgenic Antigen Driven by Endogenous Poxviral Early Promoters at Their Authentic Loci in MVASemantic proximity Read ↗

MVA and NYVAC as Vaccines against Emergent Infectious Diseases and CancerSemantic proximity Read ↗

The Poxvirus Vectors MVA and NYVAC as Gene Delivery Systems for Vaccination Against Infectious Diseases and CancerSemantic proximity Read ↗

Enhancing poxvirus vectors vaccine immunogenicitySemantic proximity Read ↗

The Evolution of Poxvirus VaccinesSemantic proximity Read ↗

Optimization in the expression of ASFV proteins for the development of subunit vaccines using poxviruses as delivery vectorsSemantic proximity Read ↗

Development of a Multi-Antigenic SARS-CoV-2 Vaccine Using a Synthetic Poxvirus PlatformSemantic proximity Read ↗

Development of a multi-antigenic SARS-CoV-2 vaccine candidate using a synthetic poxvirus platformSemantic proximity Read ↗

Use of a Novel Enhanced DNA Vaccine Vector for Preclinical Virus Vaccine InvestigationSemantic proximity Read ↗

Development of a Synthetic Poxvirus-Based SARS-CoV-2 VaccineSemantic proximity Read ↗

The use of viral vectors in vaccine developmentSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.